Back

Risk Or Benefit IN Screening for CArdiovascular Disease (ROBINSCA): the rationale and study design of a population-based randomised-controlled screening trial for cardiovascular disease

12 April 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Risk Factors and Prevention - Secondary Prevention Secondary Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Assistant Professor Carlijn Van der Aalst

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

30 More presentations in this session

Presentation thumbnail
Doctor J. Kim (Seoul, KR)
Abstract
Presentation thumbnail
Doctor T. Terada (Nottingham, GB)
Abstract
Presentation thumbnail
Doctor R. Reid (Ottawa, CA)
Abstract Slides
Presentation thumbnail
Miss P. Jepma (Amsterdam, NL)
Abstract
Presentation thumbnail
Doctor J. Coelho Lima Junior (Cambridge, GB)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Risk Factors and Prevention - Secondary Prevention

The Event

Event poster

EuroPrevent 2019

12 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Risk results from screening for a high cardiovascular disease risk by means of traditional risk factor measurement or coronary artery calcium scoring in the ROBINSCA trial
28 August 2020
thumbnail
Congress Session
Late-breaking science: diagnostic methods and assessment
17 May 2025
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
17 December 2024
thumbnail
Congress Presentation
Screening for diabetes in all patients with CVD: how to implement
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources